Abstract
Objective
To elucidate the mechanisms of 4 effective components from a Chinese medicine formula, namely Qingre Huoxue Jiedu Formula (QHJ heat- and toxin-clearing and blood-activating formula), in the treatment of nerve growth factor (NGF)-induced psoriasis.
Methods
Keratinocyte proliferation and T cell proliferation models were developed using NGF. An NGF solution (NGF+DMEM, 100 ng/mL) was added to all induced groups and treated groups and were cultured for 24 h, while a solution with NTRK1 antagonist (K252a+DEME, 300 nmol/L) was added and cultured for 1 h. The models were used to evaluate the effects of the treatment with each of the 4 components of QHJ, namely shikonin, paeonol, astilbin and ursolic acid. Cell apoptosis and proliferation were measured by flow cytometry analysis and CCK8 assay, respectively. The mRNA expression levels of Bax, Bcl-xl, and NGF receptor (NGFR) were assessed by quantitative real-time PCR (qRT-PCR) and Western blot analysis, respectively.
Results
(1) All QHJ-treated groups showed significantly increased cell apoptosis and inhibition of cell proliferation compared with the NGF-induced groups (P<0.05). In addition, treatment with QHJ plus NTRK1 significantly enhanced cell apoptosis and inhibition of cell proliferation compared with cells treated with QHJ only (P<0.05), particularly in cells treated with ursolic acid. (2) QHJ-treated groups showed higher protein expression levels of Bax, Bcl-xl compared with other groups (P<0.05). Additionally, treatment with QHJ plus NTRK1 significantly increased the protein expression levels of Bax, Bcl-xl and NGFR compared with those treated with QHJ only (all P<0.05), especially in those treated with shikonin.
Conclusion
The action mechanism of QHJ on psoriasis might be through enhancing cell apoptosis and inhibition of cell proliferation, and upregulating the expression level of Bax, Bcl-xl and NGFR.
Similar content being viewed by others
References
Boehncke WH, Schön MP. Psoriasis. Lancet 2015;386: 983–994.
Oji V, Luger TA. The skin in psoriasis: assessment and challenges. Clin Exp Rheumatol 2015;33:S14–S19.
Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk factors for the development of psoriasis. Int J Mol Sci 2019;20:4347.
Furue M, Kadono T. Psoriasis: behind the scenes. J Dermatol 2016;43:4–8.
Lee EB, Wu KK, Lee MP, Bhutani T, Wu JJ. Psoriasis risk factors and triggers. Cutis 2018;102:18–20.
Yamaguchi J, Aihara M, Kobayashi Y, Kambara T, Ikezawa Z. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis. J Dermatol Sci 2009;53:48–54.
Oishi N, Iwata H, Kambe N, Kobayashi N, Fujimoto K, Sato H, et al. Expression of precipitating factors of pruritus found in humans in an imiquimod-induced psoriasis mouse model. Heliyon 2019;5:e01981.
Schleicher SM. Psoriasis: pathogenesis, assessment, and therapeutic update. Clin Podiatr Med Surg 2016;33:355–366.
Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. Int J Mol Sci 2019;20:1475.
Zhang CS, May B, Yan Y, Yu JJ, Yao D, Chang S, et al. Terms referring to psoriasis vulgaris in the classical Chinese medicine literature: a systematic analysis. Complement Ther Med 2016;25:55–60.
Dai D, Wu H, He C, Wang X, Luo Y, Song P. Evidence and potential mechanisms of traditional Chinese medicine for the treatment of psoriasis vulgaris: a systematic review and meta-analysis. J Dermatolog Treat 2020;9:1–11.
Zhang CS, Yu JJ, Parker S, Zhang AL, May B, Lu C, et al. Oral Chinese herbal medicine combined with pharmacotherapy for psoriasis vulgaris: a systematic review. Int J Dermatol 2014;53:1305–1318.
Zhang Z, Zhao DM, Zhao WJ. Sixty cases of psoriasis treated with Qingre Huoxue Jiedu Decoction. Shaanxi J Tradit Chin Med (Chin) 2011;32:453–454.
Moos S, Mohebiany AN, Waisman A, Kurschus FC. Imiquimod-induced psoriasis in mice depends on the IL-17 signaling of keratinocytes. J Invest Dermatol 2019;139:1110–1117.
Huang TH, Lin CF, Alalaiwe A, Yang SC, Fang JY. Apoptotic or antiproliferative activity of natural products against keratinocytes for the treatment of psoriasis. Int J Mol Sci 2019;20:2558.
Pincelli C, Haake AR, Benassi L, Grassilli E, Magnoni C, Ottani D, et al. Autocrine nerve growth factor protects human keratinocytes from apoptosis through its high affinity receptor (TRK): a role for BCL-2. J Invest Dermatol 1997;109:757–764.
Minnone G, De Benedetti F, Bracci-Laudiero L. NGF and its receptors in the regulation of inflammatory response. Int J Mol Sci 2017;18:1028.
Dedoni S, Olianas MC, Ingianni A, Onali P. Type I interferons up-regulate the expression and signalling of p75 NTR/TrkA receptor complex in differentiated human SH-SY5Y neuroblastoma cells. Neuropharmacology 2014;79:321–334.
Raychaudhuri SP, Raychaudhuri SK. Role of NGF and neurogenic inflammation in the pathogenesis of psoriasis. Prog Brain Res 2004;146:433–437.
Raychaudhuri SP, Sanyal M, Weltman H, Kundu-Raychaudhuri S. K252a, a high-affinity nerve growth factor receptor blocker, improves psoriasis: an in vivo study using the severe combined immunodeficient mouse-human skin model. J Invest Dermatol 2004;122:812–819.
Renault TT, Dejean LM, Manon S. A brewing understanding of the regulation of Bax function by Bcl-xL and Bcl-2. Mech Ageing Dev 2017;161:201–210.
de Jong Y, Monderer D, Brandinelli E, Monchanin M, van den Akker BE, van Oosterwijk JG, et al. Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma. Oncogenesis 2018;7:74.
Ran LW, Wang H, Lan D, Jia HX, Yu SS. Effect of RNA interference targeting STAT3 gene combined with ultrasonic irradiation and SonoVue microbubbles on proliferation and apoptosis in keratinocytes of psoriatic lesions. Chin Med J (Engl) 2018;131:2097–2104.
Wu MF, Li S, Qian YM, Li X, Chen Y, Wei RY, et al. Combination therapy of tacrolimus and Chinese herb medicated bath in children with inverse psoriasis. Chin J Integr Med 2018;24:284–287.
Xuan ML, Lu CJ, Han L, Xiang Y. Circulating levels of inflammatory cytokines in patients with psoriasis vulgaris of different Chinese medicine syndromes. Chin J Integr Med 2015;21:108–114.
Ju JH, Cho HH, Lee YS. Progress on phytochemical and atopic dermatitis-related study of the root of Lithospermum erythrorhizon. Kor J Pharmacognosy 2010;41:73–88.
Huang C, Hu G. Shikonin suppresses proliferation and induces apoptosis in endometrioid endometrial cancer cells via modulating miR-106b/PTEN/AKT/mTOR signaling pathway. Biosci Rep 2018;38:BSR20171546.
Guo N, Miao R, Gao X, Huang D, Hu Z, Ji N, et al. Shikonin inhibits proliferation and induces apoptosis in glioma cells via downregulation of CD147. Mol Med Rep 2019;19:4335–4343.
Meng Y, Wang M, Xie X, Di T, Zhao J, Lin Y, et al. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells. Int J Mol Med 2017;39:1101–1110.
Zou W, Zhou H, Hu J, Zhang L, Tang Q, Wen X, et al. Rhizoma Smilacis Glabrae inhibits pathogen-induced upper genital tract inflammation in rats through suppression of NF-kappaB pathway. J Ethnopharmacol 2017;202:103–113.
Lin H, Song P, Zhao Y, Xue LJ, Liu Y, Chu CQ. Targeting Th17 cells with small molecules and small interference RNA. Mediators Inflamm 2015;2015:290657.
Author information
Authors and Affiliations
Contributions
Cui BN and Liu WL designed the whole study; Wang JH and Jiang YJ completed the literature search and data collection; Li M and Wang N conducted the data analysis; Wang JH wrote this thesis; all authors contributed to the interpretation of data and revision.
Corresponding author
Ethics declarations
All authors declare no conflicting interests.
Additional information
Supported by the National Natural Science Foundation of China (No. 81403398), China Academy of Chinese Medical Sciences Innovation Fund (No. CI2021A02314), and the Fundamental Research Funds for the Central Public Welfare Research Institutes (No. ZZ13-YQ-021)
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Wang, Jh., Jiang, Yj., Li, M. et al. Effects of Qingre Huoxue Jiedu Formula on Nerve Growth Factor-Induced Psoriasis. Chin. J. Integr. Med. 28, 236–242 (2022). https://doi.org/10.1007/s11655-021-3493-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-021-3493-4